<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang P</submitter><funding>National Natural Science Foundation of China</funding><pagination>1379</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9598136</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(10)</volume><pubmed_abstract>&lt;i>Acinetobacter baumannii&lt;/i> is one of the main pathogens causing nosocomial and community-acquired infections. Tigecycline is an important antibiotic for the treatment of multidrug-resistant &lt;i>A. baumannii&lt;/i> infections, but strains resistant to tigecycline have also emerged. There are still many unclear questions concerning the mechanism of tigecycline resistance in &lt;i>A. baumannii&lt;/i>. In this study, tigecycline-susceptible and tigecycline-intermediate strains were gradually cultured with sub-minimum inhibitory concentrations of tigecycline to select for tigecycline-resistant mutants, and a tigecycline-resistant strain was cultured under 42 °C to select for tigecycline-susceptible mutants. We found that the acquisition of tigecycline resistance affected the susceptibility of the str</pubmed_abstract><journal>Antibiotics (Basel, Switzerland)</journal><pubmed_title>Fitness Costs of Tigecycline Resistance in &lt;i>Acinetobacter baumannii&lt;/i> and the Resistance Mechanism Revealed by a Transposon Mutation Library.</pubmed_title><pmcid>PMC9598136</pmcid><funding_grant_id>NSFC81572041</funding_grant_id><pubmed_authors>Wang P</pubmed_authors><pubmed_authors>Zou Q</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Feng C</pubmed_authors><pubmed_authors>Lu Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fitness Costs of Tigecycline Resistance in &lt;i>Acinetobacter baumannii&lt;/i> and the Resistance Mechanism Revealed by a Transposon Mutation Library.</name><description>&lt;i>Acinetobacter baumannii&lt;/i> is one of the main pathogens causing nosocomial and community-acquired infections. Tigecycline is an important antibiotic for the treatment of multidrug-resistant &lt;i>A. baumannii&lt;/i> infections, but strains resistant to tigecycline have also emerged. There are still many unclear questions concerning the mechanism of tigecycline resistance in &lt;i>A. baumannii&lt;/i>. In this study, tigecycline-susceptible and tigecycline-intermediate strains were gradually cultured with sub-minimum inhibitory concentrations of tigecycline to select for tigecycline-resistant mutants, and a tigecycline-resistant strain was cultured under 42 °C to select for tigecycline-susceptible mutants. We found that the acquisition of tigecycline resistance affected the susceptibility of the str</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-19T12:03:30.079Z</modification><creation>2025-04-19T12:03:30.079Z</creation></dates><accession>S-EPMC9598136</accession><cross_references><pubmed>36290038</pubmed><doi>10.3390/antibiotics11101379</doi></cross_references></HashMap>